Vlastimil Kulda

1.7k total citations · 1 hit paper
50 papers, 1.4k citations indexed

About

Vlastimil Kulda is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vlastimil Kulda has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vlastimil Kulda's work include MicroRNA in disease regulation (9 papers), Bone Tissue Engineering Materials (9 papers) and Cancer-related molecular mechanisms research (8 papers). Vlastimil Kulda is often cited by papers focused on MicroRNA in disease regulation (9 papers), Bone Tissue Engineering Materials (9 papers) and Cancer-related molecular mechanisms research (8 papers). Vlastimil Kulda collaborates with scholars based in Czechia, China and Germany. Vlastimil Kulda's co-authors include Václav Babuška, Petra Chocholata, Martin Pešta, Ondřej Topolčan, Vladislav Třeška, L Holubec, Jana Dvořáková, Marie Ludvíková, Miloš Pešek and Václav Liška and has published in prestigious journals such as International Journal of Molecular Sciences, Materials and Urology.

In The Last Decade

Vlastimil Kulda

48 papers receiving 1.4k citations

Hit Papers

Fabrication of Scaffolds for Bone-Tissue Regeneration 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vlastimil Kulda Czechia 21 545 449 413 269 160 50 1.4k
Yue Song China 23 627 1.2× 603 1.3× 248 0.6× 238 0.9× 182 1.1× 51 1.5k
Elena Gabusi Italy 24 312 0.6× 538 1.2× 265 0.6× 176 0.7× 383 2.4× 69 1.9k
Ning Wen China 22 338 0.6× 587 1.3× 216 0.5× 295 1.1× 237 1.5× 74 1.6k
Yingchao Zhao China 24 232 0.4× 556 1.2× 377 0.9× 321 1.2× 120 0.8× 82 1.6k
Chongqi Tu China 18 414 0.8× 250 0.6× 161 0.4× 103 0.4× 215 1.3× 43 1.1k
Václav Babuška Czechia 17 568 1.0× 280 0.6× 178 0.4× 279 1.0× 153 1.0× 45 1.3k
Nunzia Di Maggio Switzerland 18 528 1.0× 430 1.0× 183 0.4× 225 0.8× 320 2.0× 29 1.4k
Xudong Yao China 20 533 1.0× 565 1.3× 377 0.9× 362 1.3× 329 2.1× 66 1.8k
Tengfei Zhou China 26 359 0.7× 855 1.9× 393 1.0× 195 0.7× 224 1.4× 58 2.0k

Countries citing papers authored by Vlastimil Kulda

Since Specialization
Citations

This map shows the geographic impact of Vlastimil Kulda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vlastimil Kulda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vlastimil Kulda more than expected).

Fields of papers citing papers by Vlastimil Kulda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vlastimil Kulda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vlastimil Kulda. The network helps show where Vlastimil Kulda may publish in the future.

Co-authorship network of co-authors of Vlastimil Kulda

This figure shows the co-authorship network connecting the top 25 collaborators of Vlastimil Kulda. A scholar is included among the top collaborators of Vlastimil Kulda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vlastimil Kulda. Vlastimil Kulda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pešta, Martin, Vlastimil Kulda, Pavel Ostašov, et al.. (2024). Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC). In Vivo. 38(4). 1799–1805. 1 indexed citations
3.
Pešta, Martin, et al.. (2022). Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer. Diagnostics. 12(8). 1799–1799. 16 indexed citations
4.
Babuška, Václav, et al.. (2022). Nanomaterials in Bone Regeneration. Applied Sciences. 12(13). 6793–6793. 36 indexed citations
5.
Chocholata, Petra, Vlastimil Kulda, Jana Dvořáková, et al.. (2021). In Situ Hydroxyapatite Synthesis Enhances Biocompatibility of PVA/HA Hydrogels. International Journal of Molecular Sciences. 22(17). 9335–9335. 25 indexed citations
6.
Chocholata, Petra, Vlastimil Kulda, Jana Dvořáková, Jana Dobrá, & Václav Babuška. (2020). Biological Evaluation of Polyvinyl Alcohol Hydrogels Enriched by Hyaluronic Acid and Hydroxyapatite. International Journal of Molecular Sciences. 21(16). 5719–5719. 34 indexed citations
8.
Babuška, Václav, Jana Dobrá, L. Dluhoš, et al.. (2020). Repeated Exposure of Nanostructured Titanium to Osteoblasts with Respect to Peri-Implantitis. Materials. 13(3). 697–697. 5 indexed citations
9.
Chocholata, Petra, Vlastimil Kulda, & Václav Babuška. (2019). Fabrication of Scaffolds for Bone-Tissue Regeneration. Materials. 12(4). 568–568. 461 indexed citations breakdown →
10.
Pešta, Martin, Radek Kučera, Ondřej Topolčan, et al.. (2019). Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients. Cancers. 11(6). 864–864. 33 indexed citations
11.
Babuška, Václav, et al.. (2018). Proliferation of Osteoblasts on Laser-Modified Nanostructured Titanium Surfaces. Materials. 11(10). 1827–1827. 23 indexed citations
12.
Kalfeřt, David, Marie Ludvíková, Ondřej Topolčan, et al.. (2017). Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas. Anticancer Research. 37(6). 3281–3286. 6 indexed citations
13.
Kulda, Vlastimil, Martin Svatoň, Petr Mukenšnábl, et al.. (2017). Predictive relevance of miR‑34a, miR‑224 and miR‑342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy. Oncology Letters. 15(1). 592–599. 5 indexed citations
14.
Kulda, Vlastimil, Jana Dobrá, Martin Svatoň, et al.. (2017). Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer. Anticancer Research. 37(12). 6953–6958. 4 indexed citations
15.
Kučera, Radek, Ondřej Topolčan, Marie Karlíková, et al.. (2016). Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.. PubMed. 36(4). 1967–71. 9 indexed citations
16.
Zhang, Honghe, Peiwei Li, Martin Pešta, et al.. (2014). Diagnostic and Prognostic Value of microRNA-21 in Colorectal Cancer: An Original Study and Individual Participant Data Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2783–2792. 24 indexed citations
17.
Kulda, Vlastimil. (2012). [Vitamin D metabolism].. PubMed. 58(5). 400–4. 29 indexed citations
18.
Babuška, Václav, Vlastimil Kulda, Martin Pešta, et al.. (2010). Characterization of P19 cells during retinoic acid induced differentiation.. PubMed. 111(4). 289–99. 7 indexed citations
19.
Kulda, Vlastimil, Martin Pešta, Ondřej Topolčan, et al.. (2010). Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genetics and Cytogenetics. 200(2). 154–160. 130 indexed citations
20.
Klečka, Jiří, Martin Pešta, Milan Hora, et al.. (2009). UP-1.125: Importance of miRNAs Expression in Prostate Cancer and Benign Prostate Tissue. Urology. 74(4). S209–S209. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026